5 results about "Polio virus" patented technology

The present disclosure describes, compositions and methods comprising a recombinant, chimeric poliovirus construct for the neuroinflammatory stimulation of microglia against neurodegenerative diseases. The compositions may include a chimeric poliovirus and a therapeutic agent capable of binding to protein aggregates associated with the neurodegenerative disease. Methods of treating neurodegenerative diseases and methods of activating microglia are also provided.

This application provides a poliovirus and method for treating human glioma, comprising a composition of oncolytic poliovirus and an Ommaya capsule, a delivery method, and uses.

The invention provides a method for detecting residual blood through object surface disinfection wet tissue, and relates to the technical field of medical environment, medical equipment and equipment surface cleaning detection. After the object surface disinfection wet tissue with the residual blood detection function is used for collecting surface samples of a medical environment, a medical instrument and equipment, the residual blood pollution degree of the surfaces of the medical environment, the medical instrument and the equipment is qualitatively, semi-quantitatively and quantitatively judged according to the color change of the object surface disinfection wet tissue with the residual blood detection function. The semi-quantitative detection calibrator comprises multiple stages of color blocks and subdivision grids, and the residual blood volume is calculated by counting the area proportion of different color blocks through visual inspection; according to the quantitative detection AI rule, wet tissue images are scanned through photography and analysis equipment, software analyzes the mapping relation between pixel RGB values and standard concentration, the method is easy and convenient to operate, large-batch data can be rapidly processed, the cost is remarkably reduced, and the method is particularly suitable for rapid pollution evaluation of medical environments, medical instruments and equipment surfaces. Meanwhile, the pirameton can generate a composite reaction with other components in the object surface disinfection wet tissue with the residual blood detection function, so that the sterilization and disinfection capability of the product is improved; through detection, the killing rate of the object surface disinfection wet tissue with the residual blood detection function on microorganisms such as staphylococcus aureus, escherichia coli and pseudomonas aeruginosa within one minute is as high as 99.999%, and the killing rate of the object surface disinfection wet tissue on poliovirus is as high as 99.99%.

A modified polio virus receptor (PVR / CD155) gene including one or more mutations in exons selected from exons 2, 3 and 4 of poliovirus receptor (PVR / CD155) gene having SEQ ID No.1. More specifically, cell lines including the modified gene and method of producing the same using clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated protein 9 (CRISPR-Cas9) system. The cell line is refractory (non-permissive) to poliovirus and susceptible to most Enteroviruses and many other human viruses. Further, the cell line can be applied in the fields of research, diagnostic and therapy.

The invention relates to a poliovirus primer combination, a kit and a whole-gene capturing method. The primer combination disclosed by the invention comprises primers with nucleotide sequences as shown in SEQ ID NO: 1-12, and highly conserved regions targeting PV1, PV2 and PV3 viruses, and can be specifically combined with poliovirus RNA (Ribonucleic Acid). Through targeted enrichment, library construction and sequencing signal analysis, efficient capture of the whole genome (about 7400 nucleotides) of the virus can be realized, the capture amplicons cover 99% of the virus sequence, and the virus nucleic acid with the virus load greater than or equal to 1 * 10 < 6 > copies / mL can be detected.